Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 26, 2007. The report discloses a notification of major interests in shares received from Legal & General Group plc on November 23, 2007, pursuant to Disclosure and Transparency Rules (DTR) 5.8.12.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory notification regarding share ownership thresholds and does not contain financial performance data.
Material Changes
The material change disclosed is an acquisition of voting rights by Legal & General Group plc and its subsidiaries. The transaction caused the group to cross the 5% voting rights threshold in GlaxoSmithKline plc.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It strictly details the mechanics of the shareholding notification.
Important Facts for Investors
- Shareholder: Legal & General Group plc (including Legal & General Investment Management Limited and Legal & General Assurance (Pensions Management) Limited).
- Transaction Date: November 22, 2007.
- Threshold Crossed: The group's total voting rights exceeded 5%.
- Total Voting Rights: 276,814,903 shares, representing 5.00% of the total voting rights (based on a total of 5,529,026,383 shares).
- Breakdown: Direct holdings were 256,272,494 shares (4.63%), with indirect holdings of 20,542,409 shares (0.37%).